These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12639496)

  • 1. Coproantibodies to the enteropathogenic Escherichia coli vaccine candidates BfpA and EspB in breastfed and artificially fed children.
    de Souza Campos Fernandes RC; Quintana Flores VM; Sousa de Macedo Z; Medina-Acosta E
    Vaccine; 2003 Apr; 21(15):1725-31. PubMed ID: 12639496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response of children with enteropathogenic Escherichia coli infection to the bundle-forming pilus and locus of enterocyte effacement-encoded virulence determinants.
    Martinez MB; Taddei CR; Ruiz-Tagle A; Trabulsi LR; Girón JA
    J Infect Dis; 1999 Jan; 179(1):269-74. PubMed ID: 9841853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Egg yolk anti-BfpA antibodies as a tool for recognizing and identifying enteropathogenic Escherichia coli.
    de Almeida CM; Quintana-Flores VM; Medina-Acosta E; Schriefer A; Barral-Netto M; Dias da Silva W
    Scand J Immunol; 2003 Jun; 57(6):573-82. PubMed ID: 12791096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalent transfer of human colostral IgA antibody activity for the enteropathogenic Escherichia coli bundle-forming pilus structural repeating subunit A in neonates.
    de Souza Campos Fernandes RC; Quintana Flores VM; Medina-Acosta E
    Diagn Microbiol Infect Dis; 2002 Dec; 44(4):331-6. PubMed ID: 12543537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies.
    Parissi-Crivelli A; Parissi-Crivelli JM; Girón JA
    J Clin Microbiol; 2000 Jul; 38(7):2696-700. PubMed ID: 10878066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and purification of the recombinant enteropathogenic Escherichia coli vaccine candidates BfpA and EspB.
    Quintana Flores VM; Campos de Souza Fernandes RC; Sousa de Macedo Z; Medina-Acosta E
    Protein Expr Purif; 2002 Jun; 25(1):16-22. PubMed ID: 12071694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live salmonella vaccine strain.
    Schriefer A; Maltez JR; Silva N; Stoeckle MY; Barral-Netto M; Riley LW
    Vaccine; 1999 Feb; 17(7-8):770-8. PubMed ID: 10067682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of recombinant bacillus Calmette-Guérin and Mycobacterium smegmatis expressing BfpA and intimin as vaccine vectors against enteropathogenic Escherichia coli.
    Vasconcellos HL; Scaramuzzi K; Nascimento IP; Da Costa Ferreira JM; Abe CM; Piazza RM; Kipnis A; Dias da Silva W
    Vaccine; 2012 Sep; 30(41):5999-6005. PubMed ID: 22828590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular variation among type IV pilin (bfpA) genes from diverse enteropathogenic Escherichia coli strains.
    Blank TE; Zhong H; Bell AL; Whittam TS; Donnenberg MS
    Infect Immun; 2000 Dec; 68(12):7028-38. PubMed ID: 11083828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human colostrum contains IgA antibodies reactive to enteropathogenic Escherichia coli virulence-associated proteins: intimin, BfpA, EspA, and EspB.
    Loureiro I; Frankel G; Adu-Bobie J; Dougan G; Trabulsi LR; Carneiro-Sampaio MM
    J Pediatr Gastroenterol Nutr; 1998 Aug; 27(2):166-71. PubMed ID: 9702647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of sequence variation in bundlin, the enteropathogenic Escherichia coli type IV pilin protein.
    Fernandes PJ; Guo Q; Donnenberg MS
    Infect Immun; 2007 Oct; 75(10):4687-96. PubMed ID: 17635860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytosecretion of enteropathogenic Escherichia coli pilin subunit A in transgenic tobacco and its suitability for early life vaccinology.
    Vieira da Silva J; Garcia AB; Vieira Flores VM; Sousa de Macedo Z; Medina-Acosta E
    Vaccine; 2002 May; 20(16):2091-101. PubMed ID: 11972978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and phenotypic analysis of Escherichia coli with enteropathogenic characteristics isolated from Seattle children.
    Bokete TN; Whittam TS; Wilson RA; Clausen CR; O'Callahan CM; Moseley SL; Fritsche TR; Tarr PI
    J Infect Dis; 1997 Jun; 175(6):1382-9. PubMed ID: 9180177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal priming of the murine immune system against enterohemorrhagic Escherichia coli O157:H7 using Lactococcus lactis expressing the type III secretion system protein EspB.
    Ahmed B; Loos M; Vanrompay D; Cox E
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):141-5. PubMed ID: 23102992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early acquisition of serum and saliva antibodies reactive to enteropathogenic Escherichia coli virulence-associated proteins by infants living in an endemic area.
    Carbonare CB; Carbonare SB; Carneiro-Sampaio MM
    Pediatr Allergy Immunol; 2003 Jun; 14(3):222-8. PubMed ID: 12787303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the bundle-forming pilus by enteropathogenic Escherichia coli strains of heterologous serotypes.
    Gismero-Ordoñez J; Dall'Agnol M; Trabulsi LR; Girón JA
    J Clin Microbiol; 2002 Jun; 40(6):2291-6. PubMed ID: 12037114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-specific cell adhesion of enteropathogenic Escherichia coli is mediated by type IV bundle-forming pili.
    Tobe T; Sasakawa C
    Cell Microbiol; 2002 Jan; 4(1):29-42. PubMed ID: 11856171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of the bundle-forming pilus structural gene (bfpA) among enteropathogenic Escherichia coli.
    Girón JA; Donnenberg MS; Martin WC; Jarvis KG; Kaper JB
    J Infect Dis; 1993 Oct; 168(4):1037-41. PubMed ID: 8104225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain.
    Zhu C; Feng S; Thate TE; Kaper JB; Boedeker EC
    Vaccine; 2006 May; 24(18):3845-55. PubMed ID: 16112258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.